Soleno Therapeutics, Inc. · NASDAQ:SLNO

Nantahala Capital Management, LLC's stake in Soleno Therapeutics, Inc. fell to 1.99% (Schedule 13G/A)

Event Jun 30, 2025 · Filed Aug 14, 2025

Nantahala Capital Management, LLC's stake in Soleno Therapeutics, Inc. fell to 1.99%, 1,001,350 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).

Stake
1.99%
Shares
1,001,350
Intent
Passive
What changed
Fell below 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Nantahala Capital Management, LLC1.99%1,001,350
Wilmot B. Harkey1.99%1,001,350
Daniel Mack1.99%1,001,350

Source

View original at SEC

Related